Literature DB >> 15539059

Declining seroprevalence of rubella antibodies among young Israeli adults: a 12-year comparison.

Michael Huerta1, Nadav Davidovitch, Omer E Ankol, Yona Zaaide, Itamar Grotto, Ran D Balicer, Eli Zangvil.   

Abstract

BACKGROUND: In March 2000, the Israel Defense Force (IDF) experienced an outbreak of rubella. No population-based rubella seroepidemiologic data were available for the 13-year period preceding the epidemic.
METHODS: We conducted a population-based seroprevalence study of rubella antibodies among 289 IDF recruits drafted in 1999.
RESULTS: We found that 69.2% of males and 90.8% of females in service were seropositive at recruitment in 1999, immediately before the outbreak. These rates were significantly lower than those last measured in 1987 (88% among males and 98.1% among females).
CONCLUSIONS: Our findings indicate that this rubella outbreak among young adults was facilitated by a decrease in immunity to levels below those required for herd immunity, at which epidemic virus transmission was no longer blocked. This is most likely due to widespread pediatric vaccination coverage with incomplete catch-up immunization among adolescents and young adults. These findings serve as a reminder that changes to childhood vaccination programs may affect the epidemiology of disease among older segments of the population several years after the change is implemented.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15539059     DOI: 10.1016/j.ypmed.2004.04.036

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  2 in total

1.  Rubella seroprofile of the Italian population: an 8-year comparison.

Authors:  M C Rota; A Bella; G Gabutti; C Giambi; A Filia; M Guido; A De Donno; P Crovari; M L Ciofi Degli Atti
Journal:  Epidemiol Infect       Date:  2006-11-01       Impact factor: 2.451

2.  Impact of the two-dose rubella vaccination regimen on incidence of rubella seronegativity in gravidae aged 25 years and younger.

Authors:  Shuk Yi Annie Hui; Daljit S Sahota; Terence T Lao
Journal:  PLoS One       Date:  2017-08-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.